Deka Biosciences (“Deka”), a biotech company focused on the development of novel cytokine therapies to treat cancer and inflammatory diseases, announced today the appointment of Charlotte Moser, MD, PhD, MSc, MBA as Chief Medical Officer (CMO) and Deb Kientop, MBA as Vice President, Clinical Operations.
OKC for Soccer launches community survey on future stadium
All of Oklahoma City is highly encouraged to have a say in shaping the vision for the future downtown stadium experience.